Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 68 (1), 43-49

[Non-viral Sexually Transmitted Infections - Epidemiology, Clinical Manifestations, Diagnostics and Therapy : Part 1: Gonococci]

[Article in German]
Affiliations
Review

[Non-viral Sexually Transmitted Infections - Epidemiology, Clinical Manifestations, Diagnostics and Therapy : Part 1: Gonococci]

[Article in German]
P Nenoff et al. Hautarzt.

Abstract

Approximately 1 million people are infected per day worldwide by one or more sexually transmitted infections (STI) as estimated by the World Health Organization (WHO). Gonorrhoea represents an almost exclusively sexually transmitted infection, which predominantly affects mucous membranes of the genitourinary tract. Extragenital localization of infections is also possible, e. g. in the anorectal region. Currently, only syphilis and human immunodeficiency virus (HIV) are notifiable diseases according to the Infection Protection Act in Germany. In Saxony, an extended registration ordinance according to the German Infection Protection Act is in force, which means that besides syphilis the laboratory detection of Neisseria gonorrhoeae, Chlamydia trachomatis and genital mycoplasms are also notifiable infections. In particular, beginning in 2009 in Saxony a spectacular increase of registered infections due to N. gonorrhoeae was observed and in 2015 altogether 824 infections due to N. gonorrhoeae were reported. Alarming is the increase in resistance of N. gonorrhoeae against penicillin, doxycycline, ciprofloxacin and recently also against azithromycin and third generation cephalosporins. The so-called superbug of N. gonorrhoeae, which originated in Japan with multidrug resistance against most of the currently available oral antibiotics, has now arrived in Europe. Intramuscular or intravenous injection of ceftriaxone plus oral azithromycin, each given as single dose is the standard therapy for gonorrhoea.

Keywords: Azithromycin; Cefixime; Ceftriaxone; Neisseria gonorrhoeae; Resistance.

Similar articles

See all similar articles

Cited by 1 article

References

    1. J Fam Pract. 2011 Dec;60(12):736-40 - PubMed
    1. BMC Infect Dis. 2015 Aug 11;15:321 - PubMed
    1. Emerg Infect Dis. 2016 Sep;22(9):1677-9 - PubMed
    1. APMIS. 2015 Oct;123(10):879-86 - PubMed
    1. Future Microbiol. 2012 Dec;7(12):1401-22 - PubMed

MeSH terms

LinkOut - more resources

Feedback